Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aldeyra Therapeutics

2.22
-0.0300-1.33%
Post-market: 2.220.00000.00%19:51 EDT
Volume:705.57K
Turnover:1.56M
Market Cap:132.97M
PE:-2.29
High:2.31
Open:2.22
Low:2.15
Close:2.25
Loading ...
May 01, 2020

Major Issues Report

Current report, items 5.03 and 9.01
Apr 14, 2020

Major Issues Report

8-K - Current report
Mar 12, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Mar 12, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2020

Major Issues Report

8-K - Current report
Feb 25, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 24, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 14, 2020

Major Issues Report

Current report, items 5.02 and 9.01
Jan 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Dec 03, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 07, 2019

Major Issues Report

Current report, items 2.02, 8.01, and 9.01
Oct 31, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Oct 02, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Sep 25, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities